LEADER 03267ngm  2200793 a 450 
001 9910980035103321
035   $a(CKB)4970000000175676
035   $a(UkLoHST)4904
035   $a(UkLoHST)HST5661
035   $a(EXLCZ)994970000000175676
071 50$a5661$bHenry Stewart Talks
100   $a20220404d2022      ||         v
101 0 $aeng
135   $aurcna|||a||||
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCurrent concepts for the management of patients with osteoporosis /$fE. Michael Lewiecki
210   $aLondon $cHenry Stewart Talks$d2022
215   $a1 online resource (1 streaming video file (35 min.) $ccolor, sound)
225 1 $aBone in health and disease : bone physiology and osteoporosis,$x2056-452X
225 1 $aPeriodic reports : advances in clinical interventions and research platforms,$x2056-452X
225 1 $aSmall molecule drug discovery,$x2056-452X
300   $aAnimated audio-visual presentation with synchronized narration.
300   $aTitle from title frames.
327   $aContents: History of osteoporosis care -- Assessment of fracture risk -- Imminent fracture risk -- Individualized treatment -- Sequence of therapy -- Treat-to-target -- Technology-enabled collaborative learning.
410  0$aHenry Stewart talks.$pBiomedical & life sciences collection.$pBone in health and disease.
410  0$aHenry Stewart talks.$pBiomedical & life sciences collection.$pPeriodic reports.
410  0$aHenry Stewart talks.$pBiomedical & life sciences collection.$pSmall molecule drug discovery.
606   $aBones$xDiseases
606   $aOsteoporosis$xChemotherapy
606   $aOsteoporosis$xDiagnosis
606   $aOsteoporosis$xTreatment
606   $aBone and Bones
606   $aBone Density Conservation Agents$xtherapeutic use
606   $aBone Density$xdrug effects
606   $aBone Diseases$xdrug therapy
606   $aDisease Management
606   $aOsteoporosis$xdiagnosis
606   $aOsteoporosis$xdrug therapy
606   $aOsteoporosis$xprevention & control
606   $aOsteoporosis$xtherapy
606   $aOsteoporosis, Postmenopausal
606   $aOsteoporotic Fractures$xprevention & control
606   $aPrecision Medicine
606   $aRisk Factors
615  0$aBones$xDiseases.
615  0$aOsteoporosis$xChemotherapy.
615  0$aOsteoporosis$xDiagnosis.
615  0$aOsteoporosis$xTreatment.
615  2$aBone and Bones.
615  2$aBone Density Conservation Agents$xtherapeutic use.
615  2$aBone Density$xdrug effects.
615  2$aBone Diseases$xdrug therapy.
615  2$aDisease Management.
615  2$aOsteoporosis$xdiagnosis.
615  2$aOsteoporosis$xdrug therapy.
615  2$aOsteoporosis$xprevention & control.
615  2$aOsteoporosis$xtherapy.
615  2$aOsteoporosis, Postmenopausal.
615  2$aOsteoporotic Fractures$xprevention & control.
615  2$aPrecision Medicine.
615  2$aRisk Factors.
700   $aLewiecki$b E. Michael$4spk$01788416
801  0$bUkLoHST
801  1$bUkLoHST
906   $aVIDEO
912   $a9910980035103321
996   $aCurrent concepts for the management of patients with osteoporosis$94323275
997   $aUNINA